A kinetic model of GPCRs: analysis of G protein activity, occupancy, coupling and receptor-state affinity constants

References

• DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK. Beta-arrestins and cell signaling. Annu Rev Physiol 2007;69:483–510
   PubMed Web of Science ®Google Scholar
• Lefkowitz RJ. A brief history of G-protein coupled receptors (Nobel Lecture). Angew Chem Int Ed Engl 2013;52:6366–78
   PubMed Web of Science ®Google Scholar
• Ehlert FJ, Rathbun BE. Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations. Mol Pharmacol 1990;38:148–58
   PubMed Web of Science ®Google Scholar
• Ehlert FJ. Ternary Complex Model. In: Christopoulos A, ed. Biomedical applications of computer modeling. Boca Raton: CRC Press; 2000:21–85
   Google Scholar
• Tran JA, Chang A, Matsui M, Ehlert FJ. Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors. Mol Pharmacol 2009;75:381–96
   PubMed Web of Science ®Google Scholar
• Ehlert FJ, Griffin MT. Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias. J Pharmacol Toxicol Methods 2014;69:253–79
   PubMed Web of Science ®Google Scholar
• Berrie CP, Birdsall NJ, Burgen AS, Hulme EC. Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem Biophys Res Comm 1979;87:1000–5
   PubMed Web of Science ®Google Scholar
• Childers SR, Snyder SH. Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors. Life Sci 1978;23:759–62
   PubMed Web of Science ®Google Scholar
• Freedman SB, Poat JA, Woodruff GN. Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations. J Neurochem 1981;37:608–12
   PubMed Web of Science ®Google Scholar
• Waelbroeck M, Boufrahi L, Swillens P. Seven helix receptors are enzymes catalysing G protein activation. What is the agonist Kact? J Theor Biol 1997;187:15–37
   PubMed Web of Science ®Google Scholar
• Shea LD, Neubig RR, Linderman JJ. Timing is everything the role of kinetics in G protein activation. Life Sci 2000;68:647–58
   PubMed Web of Science ®Google Scholar
• Heitzler D, Durand G, Gallay N, et al. Competing G protein-coupled receptor kinases balance G protein and β-arrestin signaling. Mol Syst Biol 2012;8:590
   PubMed Web of Science ®Google Scholar
• Vayttaden SJ, Friedman J, Tran TM, et al. Quantitative modeling of GRK-mediated beta2AR regulation. PLoS Comput Biol 2010;6:e1000647
   PubMed Web of Science ®Google Scholar
• Hein P, Frank M, Hoffmann C, et al. Dynamics of receptor/G protein coupling in living cells. Embo J 2005;24:4106–14
   PubMed Web of Science ®Google Scholar
• Hein P, Rochais F, Hoffmann C, et al. Gs activation is time-limiting in initiating receptor-mediated signaling. J Biol Chem 2006;281:33345–51
   PubMed Web of Science ®Google Scholar
• Gales C, Van Durm JJ, Schaak S, et al. Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 2006;13:778–86
   PubMed Web of Science ®Google Scholar
• Audet N, Gales C, Archer-Lahlou E, et al. Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 2008;283:15078–88
   PubMed Web of Science ®Google Scholar
• Wall MA, Coleman DE, Lee E, et al. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell 1995;83:1047–58
   PubMed Web of Science ®Google Scholar
• Lambright DG, Sondek J, Bohm A, et al. The 2.0 A crystal structure of a heterotrimeric G protein. Nature 1996;379:311–9
   PubMed Web of Science ®Google Scholar
• Rasmussen SG, DeVree BT, Zou Y, et al. Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature 2011;477:549–55
   PubMed Web of Science ®Google Scholar
• Noel JP, Hamm HE, Sigler PB. The 2.2 A crystal structure of transducin-alpha complexed with GTP gamma S. Nature 1993;366:654–63
   PubMed Web of Science ®Google Scholar
• Coleman DE, Berghuis AM, Lee E, et al. Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science 1994;265:1405–12
   PubMed Web of Science ®Google Scholar
• Traut TW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 1994;140:1–22
   PubMed Web of Science ®Google Scholar
• Black JW, Leff P. Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 1983;220:141–62
   PubMed Web of Science ®Google Scholar
• Ehlert FJ, Suga H, Griffin MT. Analysis of agonism and inverse agonism in functional assays with constitutive activity: estimation of orthosteric ligand affinity constants for active and inactive receptor states. J Pharmacol Exp Ther 2011;338:671–86
   PubMed Web of Science ®Google Scholar
• Ehlert FJ, Suga H, Griffin MT. Quantifying agonist activity at G protein-coupled receptors. J Vis Exp 2011;(58):e3179
   PubMedGoogle Scholar
• Hulme EC, Berrie CP, Birdsall NJ, Burgen AS. Two populations of binding sites for muscarinic antagonists in the rat heart. Eur J Pharmacol 1981;73:137–42
   PubMed Web of Science ®Google Scholar
• Simons PC, Biggs SM, Waller A, et al. Real-time analysis of ternary complex on particles: direct evidence for partial agonism at the agonist-receptor-G protein complex assembly step of signal transduction. J Biol Chem 2004;279:13514–21
   PubMed Web of Science ®Google Scholar
• Zurn A, Zabel U, Vilardaga JP, et al. Fluorescence resonance energy transfer analysis of alpha 2a-adrenergic receptor activation reveals distinct agonist-specific conformational changes. Mol Pharmacol 2009;75:534–41
   PubMed Web of Science ®Google Scholar
• Griffin MT, Figueroa KW, Liller S, Ehlert FJ. Estimation of agonist activity at G protein-coupled receptors: analysis of M2 muscarinic receptor signaling through Gi/o,Gs, and G15. J Pharmacol Exp Ther 2007;321:1193–207
   PubMed Web of Science ®Google Scholar
• Ehlert FJ. On the analysis of ligand directed signaling at G protein coupled receptors. NS Arch Pharmacol 2008;377:549–77
   PubMed Web of Science ®Google Scholar